http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004182674-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a869d6fc950d50f6df03f549ca3afa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
filingDate 2002-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c3035ff753b748de55963e4dd5d55f
publicationDate 2004-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2004182674-A
titleOfInvention Antitumor pharmaceutical composition containing vanillyl fatty acid amide
abstract An antitumor pharmaceutical composition having low side effects and high antitumor activity is provided. An antitumor pharmaceutical composition comprising a vanillyl fatty acid amide represented by the following chemical formula (1): Embedded image (In the formula, the —CO—R group is a saturated fatty acid residue having 14 to 32 carbon atoms, or an unsaturated fatty acid residue having 14 to 32 carbon atoms). [Effect] It has a low side effect and a high antitumor effect, in particular, an anti-melanoma effect and an anti-leukemia effect. A tumor pharmaceutical composition was obtained. [Selection diagram] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013216668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008540393-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8618165-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4819810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008069088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013508307-A
priorityDate 2002-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395240

Total number of triples: 26.